ADI
73
2
GD
64
2
V
54
2
IP
34
6
XOM
50
5
GWW
67
2
MDLZ
26
-2
WMT
55
-4
C
84
2
AME
75
3
AAL
57
3
AIZ
80
2
PCAR
56
4
OMC
66
-3
CI
52
4
LUV
70
2
RIG
43
3
IR
63
5
BEN
57
2
PAYX
41
5
ADI
73
2
GD
64
2
V
54
2
IP
34
6
XOM
50
5
GWW
67
2
MDLZ
26
-2
WMT
55
-4
C
84
2
AME
75
3
AAL
57
3
AIZ
80
2
PCAR
56
4
OMC
66
-3
CI
52
4
LUV
70
2
RIG
43
3
IR
63
5
BEN
57
2
PAYX
41
5
Financhill
Back

Invesco CurrencyShares Swiss Franc Trust Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
54

FXF
Invesco CurrencyShares Swiss Franc Trust

Last Price:
$111.64
Seasonality Move:
1.12%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$31.98
Seasonality Move:
-10.99%
Buy
54
Invesco CurrencyShares Swiss Franc Trust (FXF) is a Buy

Is Invesco CurrencyShares Swiss Franc Trust a Buy, Sell or Hold?

  • The current Invesco CurrencyShares Swiss Franc Trust [FXF] share price is $111.64. The Score for FXF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • FXF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FXF Stock Price Chart

What is Invesco CurrencyShares Swiss Franc Trust's stock price today?

  • The Invesco CurrencyShares Swiss Franc Trust share price today is $111.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FXF is experiencing slight buying pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

FXF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 62.52 Buy
Chaikin Money Flow: 23420 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (109.73 - 111.09) Buy
Bollinger Bands (100): (109.76 - 111.36) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

FXF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.23 Buy
20-day SMA: 110.47 Buy
50-day SMA: 110.56 Buy
200-day SMA: 108.8 Buy
8-day EMA: 111.14 Buy
20-day EMA: 110.75 Buy
50-day EMA: 108.73 Buy
200-day EMA: 70.7 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

Invesco CurrencyShares Swiss Franc Trust Earnings Growth & FXF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

Invesco CurrencyShares Swiss Franc Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):